688202 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Shanghai Medicilon, Inc. engages in the preclinical comprehensive research and development services of biomedicine. It provides drug discovery, pharmaceutical research, and preclinical research services. It offers AIDS drugs, anti-cancer drug sensitizers, genetically engineered vaccines and biomedical intermediates. The company was founded by Jin Zhang Chen and Chun Lin Chen on February 2, 2004 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688202 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company